Stockscreener 앱 받기
1.86
0.54%
0.01
전일 마감가:
$1.85
열려 있는:
$1.84
하루 거래량:
3.85M
Relative Volume:
5.18
시가총액:
$206.51M
수익:
$21.05M
순이익/손실:
$-142.93M
주가수익비율:
-1.3386
EPS:
-1.3895
순현금흐름:
$-184.07M
1주 성능:
+6.29%
1개월 성능:
-15.07%
6개월 성능:
+28.28%
1년 성능:
+24.00%
1일 변동 폭
$1.84
$1.955
1주일 범위
$1.715
$2.02
52주 변동 폭
$1.09
$3.3999
알렉터 Stock (ALEC) Company Profile
명칭
Alector Inc
전화
415-231-5660
주소
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.86 | 206.51M | 21.05M | -142.93M | -184.07M | -1.3895 |
VRTX
Vertex Pharmaceuticals Inc
|
491.34 | 124.70B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
632.90 | 66.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
887.18 | 55.17B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
291.37 | 38.90B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
182.08 | 38.71B | 742.00K | -1.37B | -1.07B | -7.0731 |
알렉터 Stock (ALEC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2026-03-10 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-10-22 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-10-22 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-10-22 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2025-10-22 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-10-22 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-07-28 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2024-12-17 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2024-12-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-04 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-11-29 | 재확인 | H.C. Wainwright | Buy |
| 2024-11-26 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-14 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-09-25 | 개시 | Goldman | Sell |
| 2023-09-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-09-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | 개시 | Mizuho | Buy |
| 2022-04-13 | 개시 | Goldman | Sell |
| 2022-03-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-09-27 | 개시 | William Blair | Outperform |
| 2021-01-15 | 재개 | BofA Securities | Buy |
| 2020-06-24 | 개시 | H.C. Wainwright | Buy |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-03-06 | 개시 | Citigroup | Buy |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-02-19 | 개시 | Stifel | Buy |
| 2019-11-21 | 개시 | BTIG Research | Buy |
| 2019-03-04 | 개시 | Barclays | Overweight |
| 2019-03-04 | 개시 | BofA/Merrill | Buy |
| 2019-03-04 | 개시 | Morgan Stanley | Overweight |
| 2019-03-04 | 개시 | SVB Leerink | Outperform |
모두보기
알렉터 주식(ALEC)의 최신 뉴스
0Z2 Forecast — Price Target — Prediction for 2027 - TradingView
Alector, Inc. Actuals & Estimates (NASDAQ:ALEC) - TradingView
ALEC Forecast — Price Target — Prediction for 2027 - TradingView
A2PCBM Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Alector, Inc. – GETTEX:0Z2 - TradingView
Price to sales forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Enterprise value to revenue forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Price to sales forward of Alector, Inc. – GETTEX:0Z2 - TradingView
Price to book forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Enterprise value to EBITDA forward of Alector, Inc. – GETTEX:0Z2 - TradingView
Enterprise value to EBIT forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Alector Inc (ALEC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Alector (ALEC) Stock Faces Mixed Analyst Target Changes On Tau Therapy Readthrough - Yahoo Finance
Alector Inc (ALEC) Institutional Confidence - TradingKey
Alector Inc (ALEC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Alector Inc (ALEC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alector Inc (ALEC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Alector Inc (ALEC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Alector Inc (ALEC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Alector Inc (ALEC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Alector Inc (ALEC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Alector Shareholders Back Directors, Auditor and Executive Pay - TipRanks
[8-K] Alector, Inc. Reports Material Event - Stock Titan
Alector (ALEC) director Kristine Yaffe granted 28,700 RSUs and options - Stock Titan
Alector (ALEC) director receives 28,700 RSUs and 9,450-share option grant - Stock Titan
Alector (ALEC) board member receives new RSUs and long-dated stock options - Stock Titan
Alector (NASDAQ: ALEC) director receives new RSU and stock option awards - Stock Titan
Alector (ALEC) director awarded stock and options vesting through 2027 - Stock Titan
Equity grants lift Alector (ALEC) director Errol DeSouza’s holdings - Stock Titan
Alector (NASDAQ: ALEC) director receives RSU and stock option grants - Stock Titan
Alector Inc. (ALEC) Falls 3.72% as Shares Approach Critical Support at $1.36Option Strike Build - newsline.com
ALEC Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Share Price HigherPretax Income Report - newsline.com
This Insider Has Just Sold Shares In Alector - simplywall.st
Alector Inc. (ALEC) Q1 2026 Earnings: Narrower-Than-Expected Loss Exceeds Estimates; Stock Gains Nearly 2%Pretax Income Report - newsline.com
[Form 4] Alector, Inc. Insider Trading Activity - Stock Titan
Alector (ALEC) CEO sells shares to cover RSU tax obligations - Stock Titan
Alector (ALEC) CFO Berkley sells shares to cover RSU tax obligations - Stock Titan
ALEC (NASDAQ: ALEC) Form 144 lists 3,475 restricted common shares - Stock Titan
Alector (NASDAQ: ALEC) Rule 144 notice lists RSU vesting and stock sales - Stock Titan
Alector (NASDAQ: ALEC) files to sell 132,805 RSU shares after vesting - Stock Titan
Alector halts mid-stage trial for Alzheimer’s candidate developed with GSK - MSN
ALEC Q1 2026 Earnings: Narrower Loss Surprises as Pipeline Progress Highlights Biotech ResilienceGuidance vs Actual - newsline.com
Alector (ALEC) Edges Higher with Modest Gains, Holding Above Key SupportSkew Index - newsline.com
ALEC Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Progress in Neurodegenerative Pipeline - The Legal Advocate
Alector Shares Up, Focus Turns to Pipeline After Setback - Bez Kabli
ALEC Q1 2026 Earnings: EPS Surprises with 39.95% Beat as Pipeline AdvancesInvestor Earnings Call - The Legal Advocate
ALEC Q1 2026 Earnings: Narrower-Than-Expected Loss Surprises, No Revenue YetQuarterly Earnings - thelegaladvocate.com
Alector Inc. (ALEC) Holds Steady at $2.21 as Key Support and Resistance Levels Come into FocusOrder Block - The Legal Advocate
Number of shareholders of Alector, Inc. – DUS:0Z2 - TradingView
ALEC Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Market ResponseAnalyst Consensus Shift - Město Břeclav
Alector Inc. (ALEC) Shows Resilience: Shares Up 4.25% as Biotech Sector Watches Key LevelsCalendar Spread Trade - The Legal Advocate
알렉터 (ALEC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.36%
자본화:
|
볼륨(24시간):